- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/84 - Atomes d'azote
Détention brevets de la classe C07D 239/84
Brevets de cette classe: 295
Historique des publications depuis 10 ans
|
28
|
20
|
17
|
25
|
27
|
24
|
25
|
20
|
8
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Aic246 AG & Co. KG | 28 |
17 |
| Neupharma, Inc. | 73 |
14 |
| Cornell University | 3458 |
10 |
| ArQule, Inc. | 132 |
9 |
| Blueprint Medicines Corporation | 261 |
8 |
| Gilead Sciences, Inc. | 2249 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3019 |
7 |
| Merck Patent GmbH | 5755 |
6 |
| Araxes Pharma LLC | 90 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| Abbisko Therapeutics Co., Ltd. | 123 |
6 |
| Deciphera Pharmaceuticals, LLC | 270 |
5 |
| Eisai R&D Management Co., Ltd. | 1166 |
5 |
| Merck Sharp & Dohme LLC | 3734 |
5 |
| Bristol-myers Squibb Company | 4761 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| Pfizer Inc. | 3422 |
4 |
| Convergene LLC | 12 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 879 |
4 |
| Autres propriétaires | 155 |